Ryuhjin Ahn

733 total citations
17 papers, 444 citations indexed

About

Ryuhjin Ahn is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ryuhjin Ahn has authored 17 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Immunology. Recurrent topics in Ryuhjin Ahn's work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Cells and Metastasis (3 papers). Ryuhjin Ahn is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Cells and Metastasis (3 papers). Ryuhjin Ahn collaborates with scholars based in Canada, United States and Malaysia. Ryuhjin Ahn's co-authors include Josie Ursini‐Siegel, Alicia M. Bolt, Koren K. Mann, Yoon Kow Young, Michael Hallett, Forest M. White, William J. Muller, Morag Park, Laura Jones and Dongmei Zuo and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ryuhjin Ahn

15 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryuhjin Ahn Canada	11	246	219	155	87	62	17	444
Carlos R. Gil Del Alcazar United States	7	205 0.8×	247 1.1×	73 0.5×	109 1.3×	80 1.3×	9	440
Aurélie Thuleau France	10	180 0.7×	179 0.8×	101 0.7×	108 1.2×	61 1.0×	15	378
Aida Shahrabi Netherlands	6	239 1.0×	308 1.4×	118 0.8×	94 1.1×	32 0.5×	7	463
Minhong Tang Ireland	9	256 1.0×	339 1.5×	84 0.5×	74 0.9×	58 0.9×	14	563
Florian Schelter Germany	11	192 0.8×	259 1.2×	125 0.8×	140 1.6×	26 0.4×	19	495
Wenna Jiang China	12	169 0.7×	201 0.9×	124 0.8×	124 1.4×	56 0.9×	23	400
Haley L. Peters United States	10	175 0.7×	174 0.8×	112 0.7×	81 0.9×	49 0.8×	11	381
Ranjana Kanchan United States	12	170 0.7×	242 1.1×	198 1.3×	135 1.6×	52 0.8×	20	518
Hengbo Zhou United States	12	268 1.1×	357 1.6×	97 0.6×	154 1.8×	75 1.2×	18	617

Countries citing papers authored by Ryuhjin Ahn

Since Specialization

Citations

This map shows the geographic impact of Ryuhjin Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuhjin Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuhjin Ahn more than expected).

Fields of papers citing papers by Ryuhjin Ahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuhjin Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuhjin Ahn. The network helps show where Ryuhjin Ahn may publish in the future.

Co-authorship network of co-authors of Ryuhjin Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuhjin Ahn. A scholar is included among the top collaborators of Ryuhjin Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuhjin Ahn. Ryuhjin Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ahn, Ryuhjin, Stéphane Richard, Sarah M. Maritan, et al.. (2025). Complex I inhibition combined with TLR activation in the breast tumor microenvironment educates cytotoxic neutrophils. Science Advances. 11(28). eadu5915–eadu5915.

Cui, Yufei, Ryuhjin Ahn, Lauren Stopfer, et al.. (2024). Validation and quantification of peptide antigens presented on MHCs using SureQuant. Nature Protocols. 20(5). 1196–1222. 3 indexed citations

Piranlioglu, Raziye, Ryuhjin Ahn, Hiroshi Nakashima, et al.. (2023). Assessment of The Impact of Oncolytic Virotherapy on The Immunopeptidome Profile of Tumor by Utilizing GEMM Derived Immunocompetent GBM Models. The Journal of Immunology. 210(Supplement_1). 245.11–245.11.

Ahn, Ryuhjin, Yufei Cui, & Forest M. White. (2023). Antigen discovery for the development of cancer immunotherapy. Seminars in Immunology. 66. 101733–101733. 17 indexed citations

Jaeger, Alex M., Lauren Stopfer, Ryuhjin Ahn, et al.. (2022). Deciphering the immunopeptidome in vivo reveals new tumour antigens. Nature. 607(7917). 149–155. 66 indexed citations

Totten, Stephanie, Ryuhjin Ahn, Paul Savage, et al.. (2021). p66ShcA potentiates the cytotoxic response of triple negative breast cancers to PARP inhibitors. JCI Insight. 6(4). 4 indexed citations

Ahn, Ryuhjin & Josie Ursini‐Siegel. (2021). Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors. International Journal of Molecular Sciences. 22(5). 2608–2608. 17 indexed citations

Kiepas, Alexander, Julien Senécal, Ryuhjin Ahn, et al.. (2020). The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation. Journal of Biological Chemistry. 295(31). 10535–10559. 9 indexed citations

Lewis, Kyle, Alexander Kiepas, Julien Senécal, et al.. (2020). p66ShcA functions as a contextual promoter of breast cancer metastasis. Breast Cancer Research. 22(1). 7–7. 12 indexed citations

10.

Kong, Tim, Ryuhjin Ahn, Xianbing Zhu, et al.. (2019). CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers. Cancer Research. 80(3). 444–457. 103 indexed citations

11.

Ha, Jacqueline R., Ryuhjin Ahn, Harvey W. Smith, et al.. (2018). Integration of Distinct ShcA Signaling Complexes Promotes Breast Tumor Growth and Tyrosine Kinase Inhibitor Resistance. Molecular Cancer Research. 16(5). 894–908. 6 indexed citations

12.

Gravel, Simon‐Pierre, Shawn McGuirk, Ryuhjin Ahn, et al.. (2018). Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer. Cancer Research. 78(17). 4826–4838. 11 indexed citations

13.

Ahn, Ryuhjin, Alicia M. Bolt, Steven Hébert, et al.. (2017). The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression. Nature Communications. 8(1). 14638–14638. 48 indexed citations

14.

Jones, Laura, Miranda L. Broz, Ryuhjin Ahn, et al.. (2016). STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis. Cancer Research. 76(6). 1416–1428. 84 indexed citations

15.

Young, Yoon Kow, Alicia M. Bolt, Ryuhjin Ahn, & Koren K. Mann. (2016). Analyzing the Tumor Microenvironment by Flow Cytometry. Methods in molecular biology. 1458. 95–110. 32 indexed citations

16.

Ha, Jacqueline R., Ryuhjin Ahn, Julie Livingstone, et al.. (2014). p66ShcA Promotes Breast Cancer Plasticity by Inducing an Epithelial-to-Mesenchymal Transition. Molecular and Cellular Biology. 34(19). 3689–3701. 19 indexed citations

17.

Ahn, Ryuhjin, Jacqueline R. Ha, Sean Cory, et al.. (2013). The ShcA PTB Domain Functions as a Biological Sensor of Phosphotyrosine Signaling during Breast Cancer Progression. Cancer Research. 73(14). 4521–4532. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact